Combined checkpoint immunotherapy and cytotoxic chemotherapy: Further results from a phase Ib/II trial of pembrolizumab and docetaxel or gemcitabine in patients with advanced or metastatic urothelial cancer

被引：1
|
作者：
Parikh, Mamta
Pan, Chong-xian
Beckett, Laurel
Li, Yueju
Robles, Daniel
DeVisser, Christina
Lara, Primo
机构：
[1] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA
[2] UC Davis Hlth, Comprehens Canc Ctr, Sacramento, CA USA
[3] Univ Calif Davis, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4541
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4541
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma
    Popa, IE
    Stewart, K
    Smith, FP
    Rizvi, NA
    CANCER, 2002, 95 (08) : 1714 - 1719
  • [33] Results from a phase I/Ib trial of enzalutamide and gemcitabine and cisplatin in metastatic bladder cancer (mBC).
    Gupta, Shilpa
    Dhillon, Jasreman
    Magliocco, Anthony Martin
    Puskas, John
    Caceres, Gisela
    Masawi, Fadzai
    Doronin, Yulia
    Zhang, Jingsong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [34] Phase II trial of gemcitabine plus cisplatin plus ipilimumab in patients with metastatic urothelial cancer.
    Galsky, Matt D.
    Hahn, Noah M.
    Albany, Costantine
    Fleming, Mark T.
    Starodub, Alexander
    Twardowski, Przemyslaw
    Pal, Sumanta K.
    Hauke, Ralph J.
    Sonpavde, Guru
    Oh, William K.
    Bhardwaj, Nina
    Gnjatic, Sacha
    Kim-Schulze, Seunghee
    Liu, Ziyue
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [35] Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC).
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Updated efficacy and safety results from the phase Ib/II study of surufatinib combined with camrelizumab and chemotherapy in patients with advanced colorectal cancer
    Li, Sheng
    Zhu, Liangjun
    Li, Xiaoyou
    Huang, Jiayuan
    Bao, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Phase Ib/II trial of gemcitabine, cisplatin, plus lenalidomide as first-line therapy for patients with metastatic urothelial carcinoma
    Tsao, Che-Kai
    Agarwal, Neeraj
    Apolo, Andrea Borghese
    Lee, Karen M.
    Godbold, James H.
    Oh, William K.
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [38] Primary chemotherapy with gemcitabine, doxorubicin and docetaxel for early breast cancer: Final results of a Phase-II trial
    Mross, Klaus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (07) : 423 - 424
  • [39] A phase II multicentric trial of combined chemotherapy with gemcitabine plus S-1 in patients with advanced pancreatic cancer
    Ohkawa, S.
    Amano, A.
    Ueno, M.
    Miyakawa, K.
    Sugimori, K.
    Tanaka, K.
    Kida, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma
    Urakami, Shinji
    Fujii, Yasuhisa
    Yamamoto, Shinya
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Sakura, Mizuaki
    Yano, Akihiro
    Saito, Kazutaka
    Masuda, Hitoshi
    Yonese, Junji
    Fukui, Iwao
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 35.e1 - 35.e7
12345